GlucoModicum continues progress towards commercialisation of needle free continuous glucose monitor

Helsinki, Finland, 03 October 2023 — GlucoModicum, a company transforming glucose monitoring with precise, needle-free magnetohydrodynamic technology, continues to make progress towards the development and commercialisation of its continuous glucose monitor (CGM).

Over the past two years the Company has been undertaking a major medical device programme with our design and development collaborator, Phillips-Medisize, a global leader in front-end design, development and manufacturing for highly regulated industries such as pharma, diagnostics, and medtech.

In this short video prepared by Philips-Medisize you can find out more about how GlucoModicum science and proprietary technology has been turned into a world class product, as well as a preview of what GlucoModicum’s future products will look like.